Our overall findings, coupled with previous studies supporting a role for MKP-1 in enhancing malignant characteristics of cancer cells, indicate that NSC 95397 is a viable therapeutic intervention for colon cancer via the inhibition of MKP-1 activity. Here, DUSP1 is linked to malignant colon neoplasm.